
Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling
Author(s) -
Ikuo Nakamura,
Kais Zakharia,
Bubu A. Banini,
Dalia S. Mikhail,
Tae Hyo Kim,
Ju Dong Yang,
Catherine D. Moser,
Hassan M. Shaleh,
Sarah R. Thornburgh,
Ian Walters,
Lewis R. Roberts
Publication year - 2015
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0142355
Subject(s) - hepatic stellate cell , fibroblast growth factor , platelet derived growth factor receptor , in vivo , in vitro , cancer research , chemistry , pharmacology , fibrosis , medicine , microbiology and biotechnology , biology , biochemistry , receptor , growth factor